Các bài viết có thể truy cập công khai - Kausik Kumar RayTìm hiểu thêm
Tổng thểNIHRNIHBHFMRCAHAGovernment of ItalyEuropean CommissionWellcomeDHFNHMRCCIHRGovernment of SpainVAHSFNWODFGARRSZonMwSNSFGatesMacArthurGenome CanadaCASAcademy of FinlandINSERMFCTCancer Research UKESRCFondazione CariploPCORIUK Research & InnovationLeducq Foundation, USARoyal Society UKMedical Research Future Fund, Australia
Không có ở bất kỳ nơi nào: 24
Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action
KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ...
JAMA cardiology 5 (2), 217-229, 2020
Các cơ quan ủy nhiệm: UK Medical Research Council
Effect of pitavastatin on glucose, HbA1c and incident diabetes: a meta-analysis of randomized controlled clinical trials in individuals without diabetes
AJ Vallejo-Vaz, SRK Seshasai, K Kurogi, I Michishita, T Nozue, ...
Atherosclerosis 241 (2), 409-418, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
Rationale and design of the CLEAR-outcomes trial: evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
SJ Nicholls, AM Lincoff, HE Bays, L Cho, DE Grobbee, JJP Kastelein, ...
American heart journal 235, 104-112, 2021
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia, National Institute …
Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: time to overcome multifactorial therapeutic inertia?
K Khunti, M Kosiborod, KK Ray
Diabetes, Obesity and Metabolism 20 (6), 1337-1341, 2018
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options
KK Ray, P Corral, E Morales, SJ Nicholls
The Lancet 394 (10199), 697-708, 2019
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or …
SR Wilson, MS Sabatine, SD Wiviott, KK Ray, JA De Lemos, S Zhou, ...
American heart journal 161 (6), 1147-1155. e1, 2011
Các cơ quan ủy nhiệm: US National Institutes of Health
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
J Brandts, KK Ray
Nature Reviews Cardiology 20 (9), 600-616, 2023
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Novel emerging therapies in atherosclerosis targeting lipid metabolism
M Gupta, C Blumenthal, S Chatterjee, D Bandyopadhyay, V Jain, ...
Expert Opinion on Investigational Drugs 29 (6), 611-622, 2020
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein (a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial
PM Ridker, L Lei, KK Ray, CM Ballantyne, G Bradwin, N Rifai
Journal of Clinical Lipidology 17 (2), 297-302, 2023
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey
J Schofield, M France, N Capps, R Eatough, R Yadav, K Ray, H Soran
Atherosclerosis 252, 161-165, 2016
Các cơ quan ủy nhiệm: National Institute for Health Research, UK, Wellcome Trust
Clinical implications and outcomes of the ORION Phase III trials
J Brandts, KK Ray
Future Cardiology 17 (5), 769-777, 2021
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes
KK Ray, B Nazer, R Cairns, C Michael Gibson, CP Cannon
Journal of thrombosis and thrombolysis 30, 10-13, 2010
Các cơ quan ủy nhiệm: British Heart Foundation
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update
N Alsayed, W Almahmeed, F Alnouri, K Al-Waili, H Sabbour, K Sulaiman, ...
Atherosclerosis 343, 28-50, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute for Health Research, UK
Recent trials of lipid lowering
KK Ray, CP Cannon, E Braunwald
International journal of clinical practice 61 (7), 1145-1159, 2007
Các cơ quan ủy nhiệm: British Heart Foundation
Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
J Brandts, KI Dharmayat, KK Ray, AJ Vallejo-Vaz
Current Opinion in Lipidology 31 (3), 111-118, 2020
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Small interfering RNA to proprotein convertase subtilisin/kexin type 9: transforming LDL-cholesterol-lowering strategies
J Brandts, KK Ray
Current opinion in lipidology 31 (4), 182-186, 2020
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Lipid-independent pleiotropic effects of statins in the management of acute coronary coronary syndromes
KK Ray, CP Cannon
Current Treatment Options in Cardiovascular Medicine 9 (1), 46-51, 2007
Các cơ quan ủy nhiệm: British Heart Foundation
Apabetalone–BET protein inhibition in cardiovascular disease and type 2 diabetes
J Brandts, KK Ray
Future Cardiology 16 (5), 385-395, 2020
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
The power of lipid registries for cardiovascular disease prevention
T Nishikido, KK Ray
Current Opinion in Lipidology 32 (6), 342-348, 2021
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: analysis from the TNT trial
T Nishikido, R Fayyad, S Melamed, KK Ray
Atherosclerosis 322, 8-14, 2021
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ